Laobaixing announced on October 9 that as of September 30, 2026, the company had repurchased a total of 3.24 million shares, accounting for approximately 0.43% of its total share capital, with a total repurchase amount of 41.62 million yuan and a repurchase price range of 12.55 yuan to 13.03 yuan per share. In the first half of 2026, Laobaixing achieved revenue of 10.998 billion yuan and net profit attributable to the parent company of 447 million yuan.
Laobaixing PharmacyLaobaixing repurchased 3.24 million shares for 41.62 million yuan, a shareholder-return/buyback event.
